A phase I trial of the bombesin/gastrin-releasing peptide (BN/GRP) antagonist RC3095 in patients with advanced solid malignancies - Schwartsmann, G; DiLeone, L P; Horowitz, M (Investigational new drugs, 2006)
PubMed PMID: 16505950